285
Views
0
CrossRef citations to date
0
Altmetric
Research Articles

Novel Energy Drink Improves Cognitive Function and Mood, without Influencing Myocardial Oxygen Demand or Ventricular Repolarization in Adult Gamers: A Randomized, Double-Blind, Placebo-Controlled, Crossover Trial

, , , , , , & show all
Pages 33-47 | Received 30 Jan 2023, Accepted 21 Apr 2023, Published online: 15 May 2023
 

Abstract

There are limited available data assessing the efficacy of acute energy drink consumption on cognition and gaming performance, nor on cardiovascular safety.

Objectives

To examine the efficacy of acute consumption of a novel energy drink (C4S) versus placebo for improving cognitive and gaming performance and mood. Secondarily, we examined the cardiovascular safety profile of acute C4S consumption.

Methods

Forty-five healthy, young adult video gamers completed two experimental visits in randomized order where they consumed either C4S or a placebo and then completed a validated battery of neurocognitive tests, played five video games, and completed a mood state survey. Blood pressure (BP), heart rate (HR), oxygen saturation, and electrocardiogram measurements were taken at baseline and repeated throughout each visit.

Results

Acute consumption of C4S improved cognitive flexibility (absolute mean or median difference [95% CI] = +4.3 [2.2–6.4]; p < 0.001; d = 0.63), executive function (+4.3 [2.3–6.3]; p < 0.001; d = 0.63), sustained attention (+2.1 [0.6–3.6]; p = 0.01; d = 0.44), motor speed (+2.9 [0.8–4.9]; p < 0.001; d = 0.44), psychomotor speed (+3.9 [0.1–7.7]; p = 0.04; d = 0.32) working memory (+1.0 [0.1–1.9]; p = 0.02; d = 0.35), and performance in the two-dimensional visuospatial game Tetris (+463 [-419–2,065] pts; p = 0.049; d = 0.30) compared to placebo. C4S also improved Fatigue-Inertia (-1 [-3–0]; p = 0.004; d = 0.45), Vigor-Activity (+2.4 [1.3–3.6]; p < 0.001; d = 0.64), Friendliness (+0 [0–1]; p = 0.04; d = 0.32), and Total Mood Disturbance (-3 [-6–0]; p = 0.002; d = 0.44). BP increased slightly in C4S versus placebo, while HR decreased from baseline to post-drink in the C4S condition. Rate-pressure-product was higher in C4S versus placebo independent of time but did not increase from baseline. There was no effect on corrected QT interval.

Conclusion

Acute consumption of C4S was efficacious for cognitive performance, visuospatial gaming performance, and mood enhancement, and had no effect on myocardial oxygen demand or ventricular repolarization, despite being associated with increases in BP.

Acknowledgements

The authors thank Woodbolt Distribution LLC/Nutrabolt® (Austin, TX, USA) for generously funding the study and supplying the beverages, Chris Lockwood (Dr Chris Lockwood LLC, Casper, WY, USA) for securing funding, and Edgar Grigorian and DYAD Labs (Salt Lake City, UT, USA) and Andy Holmes and LGC Science, Inc (Lexington, KY, USA) for providing third-party analytical testing of all finished products. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.

Disclosure statement

As of August 8, 2022, Chris Lockwood (CML) was employed as Vice President of Scientific Affairs for Nutrabolt® (Austin, TX). CML’s employment at Nutrabolt® began following completion of this study, which included data collection, analyses, and interpretation and completion of the primary manuscript draft. No other authors have competing interests to declare that are relevant to the content of this article.

Authors contributions

LES and NDMJ wrote the original draft of this manuscript. LES, NDMJ, NFB, EMR, NJH, JPA, SLS, and CML reviewed and edited this manuscript. Study conceptualization and methodologies were carried out by CML and NDMJ. Data curation and investigation were performed by LES, NDMJ, NJH, JPA, and SLS. Data analyses were performed by LES and NDMJ. Funding was acquired by CML and NDMJ and beverages were acquired by CML. Project administration and supervision were managed by LES, NDMJ, and CML. All other resources were provided by NDMJ. Analytical validation was overseen by CML.

Additional information

Funding

Research reported in this publication was supported by the National Center For Advancing Translational Sciences of the National Institutes of Health under Award Number UL1TR002537.

Log in via your institution

Log in to Taylor & Francis Online

PDF download + Online access

  • 48 hours access to article PDF & online version
  • Article PDF can be downloaded
  • Article PDF can be printed
USD 53.00 Add to cart

Issue Purchase

  • 30 days online access to complete issue
  • Article PDFs can be downloaded
  • Article PDFs can be printed
USD 139.00 Add to cart

* Local tax will be added as applicable

Related Research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.